Serum α1-proteinase inhibitor concentrations in dogs with exocrine pancreatic disease, chronic hepatitis or proteinuric chronic kidney disease

Vet J. 2018 Jun:236:68-71. doi: 10.1016/j.tvjl.2018.04.017. Epub 2018 Apr 30.

Abstract

Serum canine α1-proteinase inhibitor (cα1-PI) concentrations were evaluated in dogs with pancreatitis (n=24), exocrine pancreatic insufficiency (EPI; n=29), chronic hepatitis (CH; n=11) or proteinuric chronic kidney disease (CKD-P; n=61) to determine whether systemic proteinase/proteinase-inhibitor balance is altered in these conditions. Dogs with CKD-P had significantly lower cα1-PI concentrations than dogs with pancreatitis, EPI or CH; 16% of dogs with CKD-P had serum cα1-PI concentrations below the reference interval. Serum and urine cα1-PI concentrations were inversely correlated in dogs with CKD-P, but not in dogs with CH. This suggests that renal loss of cα1-PI contributes to decreased serum concentrations in dogs with CKD-P, while hepatic cα1-PI synthesis with CH either is not compromised or is counterbalanced by extrahepatic production.

Keywords: Acute phase protein; Canine; Exocrine pancreatic insufficiency; Pancreatitis; α(1)-Antitrypsin.

MeSH terms

  • Animals
  • Dog Diseases / blood*
  • Dogs
  • Female
  • Hepatitis, Chronic / blood
  • Hepatitis, Chronic / veterinary*
  • Male
  • Pancreatic Diseases / blood
  • Pancreatic Diseases / veterinary*
  • Peptide Hydrolases
  • Protease Inhibitors / blood*
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / veterinary*

Substances

  • Protease Inhibitors
  • Peptide Hydrolases